A phase II trial of chlorambucil in non-small cell lung cancer. 1987

P S Gentile, and T M Woodcock, and M S Blumenreich, and B E Epremian, and J Seeger, and S P Sheth, and J T Hamm, and E J Sherrill, and J C Allegra
Division of Medical Oncology, University of Louisville School of Medicine, KY 40292.

A Phase II trial of high-dose chlorambucil at 108 mg/m2 was undertaken in non-small cell lung cancer. No complete or partial objective responses were observed, and significant toxicity, including nausea, vomiting, and seizures, was noted. Chlorambucil at this dose and schedule of administration is not recommended for the treatment of non-small cell lung cancer.

UI MeSH Term Description Entries
D008175 Lung Neoplasms Tumors or cancer of the LUNG. Cancer of Lung,Lung Cancer,Pulmonary Cancer,Pulmonary Neoplasms,Cancer of the Lung,Neoplasms, Lung,Neoplasms, Pulmonary,Cancer, Lung,Cancer, Pulmonary,Cancers, Lung,Cancers, Pulmonary,Lung Cancers,Lung Neoplasm,Neoplasm, Lung,Neoplasm, Pulmonary,Pulmonary Cancers,Pulmonary Neoplasm
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D002289 Carcinoma, Non-Small-Cell Lung A heterogeneous aggregate of at least three distinct histological types of lung cancer, including SQUAMOUS CELL CARCINOMA; ADENOCARCINOMA; and LARGE CELL CARCINOMA. They are dealt with collectively because of their shared treatment strategy. Carcinoma, Non-Small Cell Lung,Non-Small Cell Lung Cancer,Non-Small Cell Lung Carcinoma,Non-Small-Cell Lung Carcinoma,Nonsmall Cell Lung Cancer,Carcinoma, Non Small Cell Lung,Carcinomas, Non-Small-Cell Lung,Lung Carcinoma, Non-Small-Cell,Lung Carcinomas, Non-Small-Cell,Non Small Cell Lung Carcinoma,Non-Small-Cell Lung Carcinomas
D002699 Chlorambucil A nitrogen mustard alkylating agent used as antineoplastic for chronic lymphocytic leukemia, Hodgkin's disease, and others. Although it is less toxic than most other nitrogen mustards, it has been listed as a known carcinogen in the Fourth Annual Report on Carcinogens (NTP 85-002, 1985). (Merck Index, 11th ed) 4-(Bis(2-chloroethyl)amino)benzenebutanoic Acid,Amboclorin,CB-1348,Chloraminophene,Chlorbutin,Leukeran,Lympholysin,N,N-Di-(2-chloroethyl)-p-aminophenylbutyric Acid,NSC-3088,CB 1348,CB1348,NSC 3088,NSC3088
D004341 Drug Evaluation Any process by which toxicity, metabolism, absorption, elimination, preferred route of administration, safe dosage range, etc., for a drug or group of drugs is determined through clinical assessment in humans or veterinary animals. Evaluation Studies, Drug,Drug Evaluation Studies,Drug Evaluation Study,Drug Evaluations,Evaluation Study, Drug,Evaluation, Drug,Evaluations, Drug,Studies, Drug Evaluation,Study, Drug Evaluation
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D000368 Aged A person 65 years of age or older. For a person older than 79 years, AGED, 80 AND OVER is available. Elderly

Related Publications

P S Gentile, and T M Woodcock, and M S Blumenreich, and B E Epremian, and J Seeger, and S P Sheth, and J T Hamm, and E J Sherrill, and J C Allegra
January 1985, Investigational new drugs,
P S Gentile, and T M Woodcock, and M S Blumenreich, and B E Epremian, and J Seeger, and S P Sheth, and J T Hamm, and E J Sherrill, and J C Allegra
March 1986, Cancer treatment reports,
P S Gentile, and T M Woodcock, and M S Blumenreich, and B E Epremian, and J Seeger, and S P Sheth, and J T Hamm, and E J Sherrill, and J C Allegra
September 1983, Cancer treatment reports,
P S Gentile, and T M Woodcock, and M S Blumenreich, and B E Epremian, and J Seeger, and S P Sheth, and J T Hamm, and E J Sherrill, and J C Allegra
November 1996, Anti-cancer drugs,
P S Gentile, and T M Woodcock, and M S Blumenreich, and B E Epremian, and J Seeger, and S P Sheth, and J T Hamm, and E J Sherrill, and J C Allegra
September 1997, Wiener klinische Wochenschrift,
P S Gentile, and T M Woodcock, and M S Blumenreich, and B E Epremian, and J Seeger, and S P Sheth, and J T Hamm, and E J Sherrill, and J C Allegra
May 1987, Cancer treatment reports,
P S Gentile, and T M Woodcock, and M S Blumenreich, and B E Epremian, and J Seeger, and S P Sheth, and J T Hamm, and E J Sherrill, and J C Allegra
March 1986, Cancer treatment reports,
P S Gentile, and T M Woodcock, and M S Blumenreich, and B E Epremian, and J Seeger, and S P Sheth, and J T Hamm, and E J Sherrill, and J C Allegra
March 1983, Cancer treatment reports,
P S Gentile, and T M Woodcock, and M S Blumenreich, and B E Epremian, and J Seeger, and S P Sheth, and J T Hamm, and E J Sherrill, and J C Allegra
June 1997, Seminars in oncology,
P S Gentile, and T M Woodcock, and M S Blumenreich, and B E Epremian, and J Seeger, and S P Sheth, and J T Hamm, and E J Sherrill, and J C Allegra
September 1987, Cancer treatment reports,
Copied contents to your clipboard!